Improved Detection of Metastatic Melanoma by T2*-Weighted Imaging
P. Gaviania,
M.E. Mullinsb,e,
T.A. Bragaa,
E.T. Hedley-Whytec,e,
E.F. Halpernd,e,
P.S. Schaeferb,e and
J.W. Hensona,b,e
a Stephen E. and Catherine Pappas Center for Neuro-Oncology, Harvard Medical School, Boston, Mass
b Division of Neuroradiology, Harvard Medical School, Boston, Mass
c Division of Neuropathology, Harvard Medical School, Boston, Mass
d Department of Radiology, Harvard Medical School, Boston, Mass
e Massachusetts General Hospital, Harvard Medical School, Boston, Mass

View larger version (78K):
[in a new window]
|
Fig 1. Melanoma brain metastases were detected principally on T2*-weighted sequences in 7% of 120 lesions. T1 isointense, nonenhancing lesions are seen in the right cerebellar hemisphere lesion (top row) and left frontal lobe (bottom row). A subtle abnormality can be seen on the FLAIR image (G), but the lesion is markedly more conspicuous on T2*-weighted image (H). T1-weighted sequences before (A, E) and after (B, F) administration of gadolinium, FLAIR sequences (C, G), and T2*-weighted sequences (D, H) are shown.
| |

View larger version (144K):
[in a new window]
|
Fig 2. Combined susceptibility effect and T1-weighted hyperintensity were seen in only one quarter of lesions, but this combination was 16 times more likely with melanoma than with lung cancer metastases. Intrinsic T1-weighted hyperintensity (A), minimal enhancement (B), minimal surrounding edema on a FLAIR image (C), and susceptibility effect (D) are shown in metastatic melanoma in the right frontal lobe.
| |